Cell Culture Market, by Equipment [Bioreactor, Culture Vessels (Multiwell Plates, Petri Dish)], Consumables (FBS, ABS, Media, Reagents), Application (Therapeutic, Stem Cell), End Users (Pharmaceutical and Biotechnology, Research) - Forecast to 2020

http://www.marketsandmarkets.com/Market-Reports/cell-culture-market-media-sera-reagents-559.html

The cell culture market is projected to reach USD 18,630.7 Million by 2020 from USD 11,310.9 Million in 2015. Major factors driving the growth of this market include increasing incidence of chronic diseases, increasing regulatory approvals for cell culture-based vaccines, growing demand for monoclonal antibodies (mAbs), funding for cell-based research, growing use of single-use technologies, and technological advancements in cell culture products. On the other hand, factors such as high cost of research in cell biology, and lack of infrastructure for cell-based research are likely to hinder the market growth.

In 2015, North America is expected to dominate the market, followed by Europe. However, the cell culture market in Asia is slated to grow at the highest CAGR owing to favorable regulatory guidelines, government support for cell culture-based vaccine production, low manufacturing cost, and growing focus of global market players in emerging Asian economies.

Key market players include Thermo Fisher Scientific, Inc. (U.S.), Merck KGaA (Germany), GE Healthcare (U.K.), Lonza Group AG (Switzerland), Becton, Dickinson and Company (U.S.), Corning, Inc. (U.S.), Eppendorf AG (Germany), Hi-Media Laboratories (India), Sartorius AG (Germany), and Promocell GmbH (Germany).

Stakeholders include pharmaceutical and biotechnology companies, manufacturers of cell culture equipment, contract research organizations, life science research institutes, venture capitalists, and research and consulting firms.